Anxiety Not Improving? What to Try When Medication and Therapy Aren't Enough

When Anxiety Needs More Than Medication and Talk Therapy

When standard treatment does not produce enough relief, that experience is well-documented in the clinical literature. The term clinicians use is "treatment-resistant anxiety" or "partial response," and it describes patients who do not achieve adequate symptom improvement after a full trial of first-line medication, evidence-based therapy, or both.⁶

Partial response is common. Even in the strongest published estimates, response rates for first-line anxiety medication top out around 75%, leaving roughly one in three patients needing additional options.¹ Among patients who do reach response, many do not reach remission, which means very few remaining anxiety symptoms.

The clinical next step is not to give up but to escalate or modify the plan in a structured way. That can mean adjusting what you are currently on, adding a different type of treatment alongside your current plan, or trying a treatment that works through a different biological pathway. The sections that follow walk through each of these in turn.

Put plainly: not responding fully to first-line treatment is common, and it has both a clinical name and a standard playbook.

First Steps When Anxiety Treatments Are Not Working

Before adding new treatments, the standard clinical approach is to confirm that the current treatment plan is fully realized. Several things commonly need to be checked.

• ‍The diagnosis itself. Anxiety symptoms can come from generalized anxiety disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, or a combination. Different conditions respond to different treatments, so a treatment that has not worked may simply not be matched to the underlying condition.‍
• The dose. SSRIs and SNRIs commonly used for anxiety usually require gradual upward titration to reach a therapeutic dose. A medication taken at a starting dose for several months may not have been given a fair trial.‍
• The duration. Clinical reviews note that adequate trials of SSRIs and SNRIs for generalized anxiety disorder typically run 8 to 12 weeks before full benefit can be assessed.²‍
• Medical contributors. Untreated thyroid conditions, sleep apnea, anemia, vitamin deficiencies, certain medications (steroids, stimulants), and substance use can all generate or worsen anxiety symptoms. A primary care or psychiatric workup can screen for these.‍
• The broader context. Sleep, alcohol intake, caffeine intake, chronic stressors, and unaddressed life circumstances all influence how well a treatment can work. Tracking patterns for a few weeks can surface contributors that are easier to address than they appear.

What this means in practice: many people who feel like they are not responding to treatment are actually closer to responding than they realize, once the basics get checked.

Non-medication Strategies That Can Help Anxiety Symptoms Today

Lifestyle strategies do not replace clinical treatment, but research supports them as meaningful complements that can reduce symptoms while a treatment plan is being optimized or escalated. The three with the strongest research support are structured breathing, regular exercise, and sleep regularization.

Try Deep Breathing and Grounding Exercises

Structured breathing practices can lower acute anxiety in the moment. The most-studied technique is slow paced breathing at about six breaths per minute (roughly five-second inhales and five-second exhales), which engages the parasympathetic nervous system and lowers heart rate and the body's stress response. Grounding techniques, such as naming five things you can see, four you can hear, and three you can touch, interrupt anxious rumination by anchoring attention in the present moment.

Exercise on a Regular Basis

Aerobic exercise has the strongest research support of any non-pharmacological intervention for anxiety symptoms. A 2017 meta-analysis of randomized controlled trials found that exercise produced significant reductions in anxiety symptoms compared to control conditions across multiple anxiety and stress-related disorders.⁷ The dose used in trials is typically 30 to 45 minutes of moderate-intensity aerobic exercise, three to five times per week.

Improve Sleep and Daily Routines

Poor sleep makes anxiety harder to manage, and untreated sleep disorders can keep anxiety from improving even with appropriate treatment. Standard sleep hygiene practices include consistent sleep and wake times, limiting screen use before bed, and avoiding caffeine after early afternoon. Patients with possible sleep apnea, insomnia, or other sleep disorders should be evaluated separately.

The takeaway: these are complements to treatment, not substitutes, but they can produce measurable improvement on top of clinical care.

Therapy Options for Anxiety That Go Beyond Talk Therapy

Cognitive behavioral therapy (CBT) is the most-studied psychotherapy for anxiety. Across 41 randomized placebo-controlled trials covering more than 2,800 patients, CBT showed a significant overall benefit for anxiety and related disorders.⁸ But CBT is not the only evidence-based therapy, and switching to a different modality, or working with a different therapist within the same modality, can help when an initial course has not produced enough relief.

• ‍Exposure therapy is a structured type of CBT that involves gradual, controlled contact with anxiety triggers in a safe setting. It has the strongest research support for specific phobias, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. A specialized version called exposure and response prevention (ERP) is the standard psychotherapy for OCD.‍
• Acceptance and commitment therapy (ACT) is a behavioral therapy that emphasizes accepting difficult emotions and committing to values-driven action. Meta-analytic research supports ACT as an effective option for anxiety disorders, particularly for patients who have not responded well to standard CBT.⁹‍
• Online and structured digital therapy programs have shown effectiveness in randomized trials and can be a practical option when in-person therapy is limited by access or scheduling. These programs typically deliver CBT principles through guided modules, sometimes with therapist support.

In short: if one type of therapy has not been enough, a different therapy modality, or a different therapist within the same modality, is often the right next step.

Medication Options When Symptoms Continue

When first-line medications have not produced enough relief, prescribers commonly try one or more of the following adjustments, often in combination with therapy.

Switching first-line medications. People who do not respond to one SSRI often respond to another SSRI or to an SNRI. Selective serotonin reuptake inhibitors (SSRIs) include sertraline (Zoloft), escitalopram (Lexapro), and paroxetine (Paxil); serotonin-norepinephrine reuptake inhibitors (SNRIs) include venlafaxine (Effexor) and duloxetine (Cymbalta). Clinical reviews of generalized anxiety disorder pharmacotherapy classify both classes as first-line.²

Adding or switching to a second-line medication. Several medications outside the SSRI and SNRI classes are commonly used for anxiety that has not fully responded to first-line treatment. In a leading effect-size meta-analysis of generalized anxiety disorder treatments, pregabalin (Lyrica) and hydroxyzine (Vistaril) showed effects comparable to or modestly larger than SSRIs against placebo.⁴ Buspirone, a non-benzodiazepine anxiolytic, is another option.

Benzodiazepines. Medications like alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) are typically used when first-line options have not been enough. Prescribing guidelines describe benzodiazepine therapy for adults as appropriate for short-term use of three to six months.² In the largest network meta-analysis of generalized anxiety disorder pharmacological treatments, benzodiazepines were described as "effective but also poorly tolerated" compared with placebo, with significantly higher all-cause discontinuation than placebo.¹

Combination treatment. For many people, medication plus therapy works better than either alone. If you have only tried one or the other, adding the second is often the most effective single change.

When discussing medication changes with your prescriber, helpful questions include: How long should a new medication take to work? What side effects should I watch for? If this option does not help, what comes next?

Interventional Psychiatry Options When Medication and Therapy Are Not Enough

Interventional psychiatry refers to treatments that work through different biological pathways than oral medications, typically using equipment, infusion, or specialized administration. For anxiety that has not responded to medication and therapy, three interventional options are most commonly discussed: ketamine therapy, transcranial magnetic stimulation, and electroconvulsive therapy. Each has a different evidence base, different access patterns, and different patient profiles for which it is best suited.

Ketamine Therapy for Anxiety

Ketamine is a medication that works on the N-methyl-D-aspartate (NMDA) receptor, a brain pathway that differs from SSRIs (which work on serotonin) and benzodiazepines (which work on GABA). For patients who have not responded to medications targeting serotonin or GABA, the difference in mechanism is one of the reasons ketamine therapy is increasingly offered as a next-step option for treatment-resistant anxiety.

Ketamine for anxiety is delivered through several routes: IV infusion at a clinic, intranasal esketamine (Spravato, which is FDA-approved for treatment-resistant depression but not for any anxiety disorder), and at-home sublingual lozenges administered under telehealth supervision. Treatment is typically structured as a defined course of sessions rather than as an ongoing daily medication.

The largest published real-world outcomes study of at-home ketamine therapy for anxiety, conducted by Mindbloom across more than 11,000 patients, reported that approximately 56% of patients saw their anxiety symptoms cut at least in half at four weeks, with around 29% reaching near-complete symptom reduction. In the same study, 0.4% of patients discontinued treatment due to adverse events, and 84% of patients who received a second course of treatment maintained or recovered clinically significant improvement.⁵

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) uses targeted magnetic pulses delivered to specific brain regions through a coil placed against the scalp. TMS is FDA-cleared for major depressive disorder and obsessive-compulsive disorder, and clinicians sometimes use it off-label for treatment-resistant anxiety. A 2019 systematic review and meta-analysis found moderate effects of TMS across several anxiety and trauma-related disorders, though the evidence base remains smaller than for depression.¹⁰ Treatment is typically delivered in daily sessions over four to six weeks at a specialized clinic. It is non-invasive, does not require anesthesia, and does not require recovery time after each session.

Electroconvulsive Therapy

Electroconvulsive therapy (ECT) is the oldest interventional psychiatric treatment, used primarily for severe, treatment-resistant depression, including cases with significant suicidal risk or psychotic features. ECT is occasionally used for severe anxiety in the context of depression or catatonia, but it is rarely a first or second interventional option for anxiety alone. Treatment is delivered under anesthesia at a hospital or specialized clinic over multiple sessions.

The takeaway: interventional options exist when standard treatments are not enough, and which one is right depends on diagnosis, severity, prior treatment history, and access.

Questions to Ask Your Provider

If you are not getting enough relief from your current treatment, the next step is a focused conversation with the clinician who manages your anxiety care. The following questions can help structure that conversation.

• Could my symptoms reflect a different or co-occurring condition (such as post-traumatic stress disorder, obsessive-compulsive disorder, or a medical issue affecting mood) that might respond to different treatment?
• Has my current medication been at a therapeutic dose for at least 8 to 12 weeks? If not, what would a full trial look like?
• If I have only tried medication, would adding therapy help? If I have only tried therapy, would adding medication help?
• What second-line medications or alternative therapy approaches would you recommend trying next, and why?
• Am I a candidate for interventional treatments like ketamine therapy, transcranial magnetic stimulation, or electroconvulsive therapy? If so, how would I access them?

There is no single right answer for treatment-resistant anxiety, and finding the right combination often takes more than one attempt. The clinical playbook is real, but the path through it is individual.